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ABSTRACT
Endoribonuclease Y (RNase Y) is a crucial regulator of virulence in Gram-positive bacteria. In the human
pathogen Streptococcus pyogenes, RNase Y is required for the expression of the major secreted virulence
factor streptococcal pyrogenic exotoxin B (SpeB), but the mechanism involved in this regulation remains
elusive. Here, we demonstrate that the 5′ untranslated region of speB mRNA is processed by several
RNases including RNase Y. In particular, we identify two RNase Y cleavage sites located downstream of a
guanosine (G) residue. To assess whether this nucleotide is required for RNase Y activity in vivo, we
mutated it and demonstrate that the presence of this G residue is essential for the processing of the
speB mRNA 5′ UTR by RNase Y. Although RNase Y directly targets and processes speB, we show that
RNase Y-mediated regulation of speB expression occurs primarily at the transcriptional level and
independently of the processing in the speB mRNA 5′ UTR. To conclude, we demonstrate for the first
time that RNase Y processing of an mRNA target requires the presence of a G. We also provide new
insights on the speB 5′ UTR and on the role of RNase Y in speB regulation.
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Bacterial pathogens employ a plethora of mechanisms to
tightly control the expression of their virulence factors.
Among these mechanisms, RNA-mediated regulation pro-
vides bacteria with an efficient strategy to quickly respond
to environmental stimuli [1,2]. Ribonucleases (RNases) play a
critical role in RNA metabolism and have been largely asso-
ciated with the regulation of factors involved in bacterial
pathogenicity [3,4]. In particular, the single-stranded specific
endoribonuclease Y (RNase Y) is crucial for the virulence of
Gram-positive pathogens such as Staphyloccocus aureus,
Clostridium perfringens and Streptococcus pyogenes [5–9]. In
S. aureus, RNase Y stabilizes the mRNA coding for the two-
component system SaeRS, which acts as a general regulator of
virulence [8,10]. It also controls virulence gene expression
indirectly, by affecting for example the production and stabi-
lity of potential pathogenicity regulators such as the small
RNAs (sRNAs) rsaA and sau63 [8]. In C. perfringens, RNase
Y regulates the expression of multiple virulence proteins. For
example, upon binding of the sRNA VR-RNA, RNase Y
processes the transcript coding for the collagenase toxin
(ColA), resulting in increased stability of this transcript [9].
In S. pyogenes, RNase Y affects the expression of numerous
virulence genes during the stationary growth phase [7].
However, the mechanisms by which RNase Y controls viru-
lence expression in this bacterium are uncharacterized [7,11].
In some of the RNase Y targets described, the processing
was shown to occur in proximity of RNA structures and in
adenosine/uridine rich regions [10,12]. For instance, RNase Y
cleaves the yitJ riboswitch and the sae mRNA operon
upstream of double-stranded RNA structures, in Bacillus sub-
tilis and S. aureus respectively [10,12]. In S. aureus, RNase Y
processing events were found preferentially after a guanosine
(G) [13]. Yet, direct evidence of the signals required for RNase
Y to process RNAs in those bacteria is missing and nothing is
known about the requirements for RNase Y processing in S.
pyogenes.
S. pyogenes is a strict human pathogen that causes a
broad range of diseases from mild to life-threatening infec-
tions [14]. In this bacterium, RNase Y affects the expression
of a major virulence factor, the cysteine protease strepto-
coccal pyogenic exotoxin B (SpeB) [7,11]. SpeB is the most
abundant secreted protein from S. pyogenes. It degrades a
variety of substrates, both from the bacteria and the host
[15,16]. The degradation of streptococcal surface proteins
and components of the host tissue by SpeB increases bac-
terial dissemination [15,16]. The production of SpeB is also
particularly crucial in the development of necrotizing fascii-
tis [17,18] and acute post-streptococcal glomerulonephritis
[19], two severe diseases associated to infections by S. pyo-
genes. SpeB is produced as an inactive zymogen, which
undergoes maturation processes to become active. The
CONTACT Anaïs Le Rhun lerhun@mpiib-berlin.mpg.de; Emmanuelle Charpentier research-charpentier@mpiib-berlin.mpg.de Max Planck Unit for the
Science of Pathogens, Berlin D-10117, Germany
This article has been republished with minor changes. These changes do not impact the academic content of the article.
Supplemental data for this article can be accessed here.
RNA BIOLOGY
2018, VOL. 15, NO. 10, 1336–1347
https://doi.org/10.1080/15476286.2018.1532253
© 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
biogenesis of the active SpeB protease is tightly regulated at
both transcriptional and post-translational levels [20]. speB
expression is controlled by various transcriptional regula-
tors, including the well-characterized regulator of protease B
(RopB) [21–23]. RopB binds at direct and inverted repeats
located upstream of the speB promoter to induce speB
expression [23,24]. The speB and ropB genes are adjacent
on the chromosome and transcribed in opposite directions.
A 940 nt-long intergenic region separates these two genes
and contains numerous features [23]. It consists of two
predicted open reading frames (ORFs) of unknown function
[25] and also encodes the SpeB Inducing Peptide (SIP)
involved in RopB-mediated regulation of speB expression
[26]. It has recently been shown that a partial deletion of
the speB 5′ UTR results in a global accumulation of mRNAs
at the stationary phase of growth [27]. speB harbours a long
5′ UTR where two transcriptional start sites (TSSs), named
P1 and P2, were originally predicted 697 nt and 137 nt
upstream of the speB start codon, respectively [28].
Despite the important regulatory role of the intergenic
region in speB expression, the annotation of this region is
not consistent in the literature [21,23,26–29].
In a strain lacking RNase Y (Δrny), both speB mRNA and
SpeB protein levels are highly downregulated [7,11]. Although
previous reports proposed that RNase Y processes the speB
transcript [11,30], this has never been validated. In addition, it
has been hypothesized that several RNases target the speB
mRNA 5′ UTR, but their identities and their effects on speB
transcript abundance and stability are currently unknown [27].
Therefore, the molecular mechanism of RNase Y-mediated reg-
ulation of speB expression remains to be deciphered.
Here, we investigated the RNase Y-based regulation of speB
expression and provide insight into the mechanism of RNase Y
activity in S. pyogenes. We re-annotated speB TSSs and describe
that at least two RNases, including RNase Y, process the 5′ UTR of
speBmRNA.We show for the first time that aG residue is required
for the processing of the speB transcript by RNase Y. Lastly, we
demonstrate that RNase Y also activates the transcription of speB.
Results
Characterization and re-annotation of the speB 5′ UTR
To characterize and identify additional features of the speBmRNA
5′ UTR, we performed total RNA sequencing of S. pyogenes
M1GAS strain SF370 at early stationary phase of growth. Using
these data, we annotated the 5′ boundaries of speB mRNA and
identified two putative TSSs located 697 and 842 nt from the start
codon of speB (Figs. 1A and S1A). Wemapped the –10 boxes of P
and P1 promoters by visual screening, and identified a putative –
Figure 1. Characterization and re-annotation of speB 5′ UTR.
(A) Expression profile of speB locus with surrounding genes (purple arrows) and putative open reading frames (ORFs, grey arrows) obtained by RNA sequencing
analysis. Total coverages (black for positive strand, grey for negative strand) are indicated between square brackets. The genomic coordinates are shown and the
putative promoters and terminators are indicated. prsA (encoding the foldase protein PrsA) is involved in the maturation of SpeB protease [28]. SPy_2038 was
described to encode an inhibitor of SpeB protease activity [58]. ropB (encoding for the Regulator of protease B) is a transcriptional activator of speB expression [23].
The speB−ropB intergenic region contains several putative ORFs: SPy_2040, orf-2, the SpeB Inducing Peptide (SIP) and SPy_2041. P and P1 are the speB transcriptional
start sites (TSSs); P2 depicts a 5′ end previously described as a speB TSS [23] and recently annotated as a processing site [27]. Features within the grey rectangles in
the speB 5′ UTR are shown in more detail in Figs. 1B and 2–S2. (B) Expression profile of a portion of the speB 5′ UTR obtained by RNA sequencing analysis. Total
and 5′ end coverages are indicated between square brackets. speB TSSs designated as P and P1 at positions –842 nt and –697 nt relative to the speB start codon,
respectively, are shown with black bent arrows. A putative ORF (SPy_2041) and SpeB inducing peptide (SIP) are represented in grey. The green lines depict the length
of cDNA products obtained by primer extension analyses and the primer used for the reaction is represented by the black arrows. (C) Validation of speB mRNA 5′ ends
by primer extension analyses in the WT strain at early-logarithmic (EL), mid-logarithmic (ML) and early-stationary (ES) growth phases. The bands corresponding to the
cDNA products, starting from the primer and terminating to the P or P1 5′ end, are indicated.
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35 motif for P. Both P and P1 TSSs were validated by primer
extension analyses at early-logarithmic (EL), mid-logarithmic
(ML) and early-stationary (ES) growth phases (Fig. 1B,C).
Previous studies show that the RopB binding sites are located
upstreamof P and P1 [23,26], indicating that RopB could promote
speB expression from both promoters (Fig. S1A). In agreement
with our data, P1 (–697 nt) was previously described as a speB TSS
[23] and position P (–842 nt) was recently captured by 5′ rapid
amplification of cDNA ends but not further characterized [27].
The ropB-speB intergenic region harbors several poorly
characterized small ORFs. Originally, two putative ORFs
were annotated: SPy_2040 (upstream of speB) and SPy_2041
(upstream of ropB) [25] (Fig. S1B). A different organization of
the intergenic region has recently been proposed: three ORFs
were annotated, SPy_2040 (named orf-3) SIP and orf-2 [26].
In accordance with this annotation, RNA sequencing reveals
that SPy_2041 is not transcribed in our experimental condi-
tions (Fig. S1B). Indeed, a single TSS (PropB) was mapped
downstream of the SPy_2041 start codon, at position –
369 nt relative to the ropB start codon.
The speB mRNA 5′ UTR is targeted by ribonucleases
An additional TSS (P2) located 137 nt upstream of the speB
start codon was previously proposed, however this promoter
was not sufficient to initiate transcription of a reporter gene in
the absence of P1 [23]. Recently, it has been hypothesized that
this 5′ end, located in the 5′ UTR, results from processing of
the speB mRNA [27]. We also observed a transcript 5′ end at
the original P2 position by RNA sequencing, but failed to
identify putative – 10 and – 35 boxes. To investigate the origin
of this 5′ end, we performed primer extension analyses on this
region of speB using total RNA from wild type (WT) and
strains deleted from various endoRNases and exoRNases
(Figs. 2A and S2A). A cDNA fragment corresponding to a
transcript starting at P2 (–137 nt) was detected in all the
strains tested except in Δrny, indicating that RNase Y is
involved in producing this 5′ end (Figs. 2B and S2A).
Therefore, we re-annotated P2 as a processing site of RNase
Y. A second RNase Y processing event was also retrieved in
the speB 5′ UTR, 6 nt downstream of P2, and further validated
(Fig. 2A,B). Interestingly, both processing events were located
after a G (Fig. 2C), which was confirmed by primer extension
analyses (Fig. 2D). These two transcript 5′ ends were both
present in the complemented rny deletion mutant (Δrny::rny)
(Fig. 2B,D).
We also detected an additional transcript 5′ end located
77–78 nt upstream of the speB start codon by RNA sequen-
cing and primer extension (Figs. 2A and S2). A search for –
10 and – 35 motifs located upstream of this 5′ end was
unsuccessful. In a previous study, reporter fusions contain-
ing up to 623 bp upstream of this 5′ end were not
Figure 2. The speB mRNA 5′ UTR is targeted by ribonucleases.
(A) RNA sequencing data and annotation of processing sites in the speB mRNA 5′ UTR. This region of interest is highlighted by a grey rectangle and shown in the
context of the complete locus in Fig. 1A. The total and 5′ end coverages are indicated between square brackets. The positions corresponding to the cleavage sites by
RNase Y and by unidentified RNase(s) are represented with orange and grey triangles, respectively. The bent grey arrow indicates a 5′ end previously described as a
speB TSS (P2) [23] and re-annotated as a RNase Y processing site in this study. (B) Primer extension analyses of transcripts starting at P2 position in WT, rny (RNase Y)
deletion mutant (Δrny) and chromosomal complemented rny deletion mutant (Δrny::rny) at early-stationary (ES) growth phase. The primer (black arrow) anneals to
the speB 5′ UTR (curved black line) upstream of the processing by RNase Y (orange scissors) and by unidentified RNase(s) (grey scissor). The expected cDNA products
(green lines) starting from the primer and ending to the cleavage sites are shown beside the corresponding bands. (C) Zoom on RNase Y cleavages confirmed by
primer extension in the speB mRNA 5′ UTR (orange triangles and scissors) at positions –131 nt and –137 nt relative to the speB start codon and mapped after a
guanosine (G). (D) Primer extension analyses showing RNase Y processing sites of speB mRNA 5′ UTR in WT, Δrny and Δrny::rny strains at ES growth phase. A
sequencing ladder was used in order to annotate the RNase Y processing sites at the exact nucleotide position (orange triangles). The lanes C, U, A and G indicate the
RNA sequence in the region of interest.
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expressed, indicating the lack of promoter activity in this
region [23]. Therefore, we hypothesized that this 5′ end
resulted from the processing of speB mRNA 5′ UTR. We
could not pinpoint the RNase(s) responsible for this event
as the processing site was detected in all RNase deletion
mutant strains analyzed (Fig. S2A). This processing is prob-
ably carried out by RNases that were not included in this
study, for instance RNases J1 or J2, which are essential for
S. pyogenes survival [31]. We also cannot exclude that more
than one RNase is capable of cleaving at this specific posi-
tion (i.e. when one RNase is deleted, the processing is
carried out by alternative RNase(s)), a phenomenon defined
as functional redundancy.
Characterization of RNase Y processing sites in the speB
mRNA 5′ UTR
It has previously been described that processing of transcripts
by RNase Y occurs in 58% of the cases downstream of a G in
S. aureus [13], but whether the presence of this nucleotide is
essential for RNase Y activity was never investigated. To
further examine the requirements for speB 5′ UTR processing,
we ectopically expressed speB 5′ UTR and ORF under the
control of a constitutive promoter (PgyrA) in a speB deletion
mutant (ΔspeB). The two Gs located upstream of the RNase Y
processing sites at positions –137 nt (G1) and –131 nt (G2)
were independently or simultaneously substituted by
Figure 3. RNase Y requires a guanosine to process the 5′ UTR of speB mRNA.
Characterization of speB mRNA processing by a mutational analysis of RNase Y cleavage sites. Primer extensions were performed at early-stationary growth phase in a
speB deletion mutant (ΔspeB) containing different plasmids (top panel) expressing speB (including the 5′ UTR) under the control of a constitutive promoter. The
primer (black arrow) anneals to the region corresponding to the beginning of the speB ORF. An empty vector was used as a control (Lane n°1). The cDNA products
are depicted with green lines (a, b, c and d/e). G-to-A substitutions upstream of the RNase Y processing sites at positions –137 nt (G1) and –131 nt (G2) were done as
indicated (lanes n° 2, 3, 4, 5). Plasmids used in lanes 6 (Δ26) and 7 (Δ46) harbor a deletion of 10 nt and 20 nt both upstream and downstream of RNase Y cleavages,
respectively. Dark orange triangles represent RNase Y processing sites in the 5′ UTR of speB mRNA. Light orange triangles indicate putative alternative RNase Y
processing sites.
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adenosine (A) (Fig. 3, top panels). In addition, we deleted
26 nt (Δ26) or 46 nt (Δ46) encompassing the RNase Y clea-
vage sites (Fig. 3, top panels). The effect of these mutations on
RNase Y processing was examined by primer extension ana-
lyses (Fig. 3, bottom panel). While the substitution of G1 by
A1 strongly reduced RNase Y processing (Fig. 3; lanes 3 and
5), that of G2 by A2 fully inhibited it (Fig. 3; lanes 4 and 5).
When G1 was substituted by A1, an alternative cleavage site
was detected a few nucleotides upstream of the original RNase
Y processing site (Fig. 3; lanes 3 and 5). Interestingly, this
alternative processing was also located after a G, 2 nt
upstream of the initial RNase Y processing. Additionally,
when 10 nt upstream and downstream of the processing site
of RNase Y were removed, a substitute processing site in the
speB mRNA 5′ UTR was also detected (Fig. 3; lane 6). We
analyzed the speB 5′ UTR sequence and found two Gs (posi-
tions –115 nt and –116 nt relative to the speB start codon)
possibly corresponding to those alternative processing events
(Fig. 3; lane 6) likely generated by RNase Y. Finally, a deletion
of 20 nt both upstream and downstream of the RNase Y
processing sites completely abrogated the cleavages (Fig. 3;
lane 7). Thus, we prove here for the first time that a G located
just upstream of a RNase Y cleavage site is essential for the
processing by this enzyme, in S. pyogenes and for the speB
mRNA 5′ UTR.
To assess the structural context around RNase Y cleavages,
we predicted the secondary structure of speB mRNA 5′ UTR
neighboring the first RNase Y cleavage site (100 nt upstream
and downstream) (Fig. S3A). The RNase Y processing events
were located in a poorly structured region, coherent with the
fact that RNase Y cleaves single-stranded RNA (Fig. S3A). We
observed a decrease in the minimum free energy (ΔG), indi-
cating the presence of a secondary structure approximately
40 nt downstream of the RNase Y cleavage sites (Fig. S3A,B).
This result is in contrast to what was recently shown in
S. aureus, where RNase Y recognizes a secondary structure
element located 6 nt downstream of the processing event [10].
A model in which RNase Y processing occurs through a 6 nt
(from the structure) ruler and cut mechanism was proposed.
A similar scenario was previously observed in B. subtilis,
where RNase Y processes the yitJ riboswitch, 6 nt upstream
of the aptamer structure [12]. In speB mRNA, RNase Y
processing events were 6 nt apart, however as mentioned
above in a poorly structured region, and thus it would be
unlikely that the ruler and cut mechanism by RNase Y is
applicable for speB mRNA in S. pyogenes.
speB mRNA abundance is downregulated in Δrny
In order to study the effect of RNase Y processing in speB
regulation, we analyzed the temporal pattern of speB expression
by Northern blot analysis and the production of SpeB protease
by SDS-PAGE (Fig. 4). speB expression was previously shown
to be growth phase dependent and affected by nutritional and
environmental conditions [20]. In accordance with those data,
we observed an increase of speB mRNA abundance from EL to
ES growth phases (Fig. 4A). Three distinct groups of speB
isoforms were detected by using a primer targeting speB 5′
UTR. Co-transcription of speB together with the genes located
immediately downstream (SPy_2038 and prsA2) led to the
Figure 4. RNase Y regulates speB expression.
(A–B) speB transcript abundance assessed by Northern blot analysis performed in WT, rny (RNase Y) deletion mutant (Δrny) and chromosomal complemented rny
deletion mutant (Δrny::rny) grown until early-logarithmic (EL), mid-logarithmic (ML) and early-stationary (ES) growth phases. The primers used target speB mRNA 5′
UTR (A) or speB CDS (B), see also Fig. S4. (C) Analysis of SpeB protein levels in WT, Δrny and Δrny::rny. Extracellular protein fractions from ML and ES growth phases,
resolved by SDS-PAGE and visualized by Coomassie blue staining. SpeB zymogen (SpeBz, 40 kDa) and SpeB mature form (SpeBm, 28 kDa) are indicated. (D) Study of
speB transcript stability by rifampicin assay at ES growth phase (left panel). The minutes after stopping transcription upon addition of the antibiotic are indicated. The
transcript isoforms detected (T1, T2, T3, T4 and T5) and the primer used for the hybridization reaction are shown in Fig. S4. 16S rRNA was used as a loading control.
The calculated half-lives in minutes of T2 and T3 isoforms are shown in the right panel. The half-life of T1 isoforms could not be determined with accuracy due to the
intense background of the blots. The values shown indicate the average ± standard deviation. The half-lives were compared using a t-test, single and double
asterisks denote a p-value inferior of 0.05 and 0.01, respectively. NS indicates no significant difference.
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production of ~4 kb transcripts (T1) (Figs. 4A and S4). The
most abundant transcripts, T2, arose from speB promoters and
ended at the SPy_2038 terminator (Figs. 4A and S4). Smaller
isoforms (T3) which could derive from the cleavages of speB
mRNA by RNase Y and/or by unknown RNase(s) were also
detected (Figs. 4A and S4). However, since T3 isoforms were
not visible in Δrny, they probably resulted mostly from RNase
Y processing. The processed isoforms produced by unidenti-
fied RNase(s) were not detected (Fig. 4A). It is possible that the
upstream transcripts derived from cleavage by the unidentified
RNase(s) were rapidly degraded in contrast to that produced by
RNase Y. Using a primer binding to the speB coding DNA
sequence (CDS), two additional isoforms (T4 and T5), down-
stream of the processing events in the speB mRNA 5′ UTR,
were observed (Figs. 4B and S4). The most abundant isoforms
were T5 rather than the primary transcripts (T2) (Figs. 4B and
S4). We hypothesize that the T5 isoforms observed in Δrny
were generated by the unidentified RNase(s). The speB tran-
script abundance was strongly reduced at both ML and ES
stationary growth phases in the Δrny mutant and restored in
Δrny::rny (Fig. 4A). In agreement with this result, the level of
extracellular SpeB protease, decreased in Δrny, was rescued in
Δrny::rny (Fig. 4C).
To assess if the decrease of speB abundance in Δrny was
due to a reduction of speB transcript stability, we performed
rifampicin assays (Fig. 4D). We did not observe any destabi-
lization of speB transcripts in the absence of RNase Y. On the
contrary, the half-life of the speB isoforms T2 was higher in
Δrny (40 min ± 3.34) compared to WT (19.57 min ± 2)
(Fig. 4D), confirming that RNase Y cleaved this transcript.
RNase Y regulates speB expression at the transcriptional
level
As speB transcript stability was not decreased in Δrny, we pos-
tulated that speB downregulation in this strain could be due to
indirect transcriptional effects. To test this hypothesis, the
expression of a reporter gene (firefly luciferase) under the con-
trol of the speB promoters was tested inWT, Δrny and Δrny::rny
(Figs. 5 and S5A). The luminescence signal in Δrny was really
low, indicating that the speB promoters were less active in this
strain (Fig. 5). In Δrny::rny, the activity of the speB promoters
was restored to theWT level. To exclude possible autoregulatory
effects in these conditions, the speB promoter activity was also
assessed in the ΔspeB mutant. Our data show that the lumines-
cence signals were comparable in WT and ΔspeB (Fig. S5B).
Although RNase Y cleaves speB mRNA, we showed that
the decrease of speB levels in Δrny is not a direct consequence
of this processing. Rather, RNase Y is indirectly involved in
the activation of speB promoters. Taken together, our data
indicate that, in S. pyogenes SF370 strain, RNase Y mainly
modulates speB expression at the transcriptional level through
an unknown intermediate factor.
speB expression is controlled by several transcriptional reg-
ulators, but their regulation by RNase Y is poorly described
(Supplementary Table II). We tested, in our conditions, the
stability of the covRS transcript, encoding the CovRS two-com-
ponent system, a repressor of speB transcription. The covRS
transcript stability was highly increased in Δrny compared to
the WT strain (Fig. S6), as previously suggested [29]. Therefore,
CovRS could be the missing link between RNase Y and speB.
Discussion
In this study, we investigated the role of RNases, in particular
RNase Y, in the regulation of the virulence factor SpeB in S.
pyogenes. In an effort to provide coherence for future studies
– the annotation of the speB 5′ UTR has been inconsistent in
previous works [23,26–28] –, we first determined speB tran-
script boundaries. We demonstrated that RNase Y and so far
unidentified RNase(s) process the 5′ UTR of speB mRNA.
Yet, the consequences of these processing events remain
unknown and we propose different scenarios. Processing of
speB mRNA 5′ UTR could lead to the production of a mature
form of speB mRNA that would affect the translation of speB
mRNA. For instance, in S. aureus, the processing of the 5′
UTR of cpsA mRNA (encoding a major cold shock protein)
by RNase III promotes ribosome binding and translation of
cpsA mRNA [32]. In addition, the truncation of the speB 5′
UTR was shown to induce an early onset of speB expression
and an increase of bulk mRNA stability [27]. Therefore, it is
also possible that the processed speB 5′ UTR functions as a
Figure 5. RNase Y regulates speB expression at the transcriptional level.
The speB promoter activity was examined by luminescence assays performed in WT, rny (RNase Y) deletion mutant (Δrny) and chromosomal complemented rny
deletion mutant (Δrny::rny), containing the luciferase fusion plasmids (P23-ffluc (pEC2248) and PspeB-ffluc (pEC2173), see also Fig. S5A) at mid-logarithmic (ML, left
panel) and early-stationary (ES, right panel) growth phases. Values indicate the luminescence intensity of the samples relative to the plasmid control (P23-ffluc),
normalized to the OD620 nm. Mean and standard (error bars) deviations were calculated from three independent experiments, each with technical triplicates.
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trans-acting regulatory molecule. Indeed, RNA sequencing
analyses previously revealed the presence of a putative sRNA
(Spy_sRNA1699993) located in the speB 5′ UTR [33]
(depicted in Fig. S7). Interestingly, the sRNA 5′ end corre-
sponds to the RNase Y cleavage site annotated at –137 nt
from the speB start codon, therefore the biogenesis of this
sRNA could result from RNase Y processing of speB mRNA
5′ UTR. Remarkably, the cleavage site performed by the
unidentified RNase lies between the sRNA 5′ and 3′ ends
(Fig. S7) suggesting that the sRNA is functional. Indeed,
RNase processing represents a common mechanism to gen-
erate active sRNAs [34–36]. Alternatively, the entire 5′ UTR
could act as a trans-acting RNA similar to the 5′ UTR of irvA
mRNA of Streptococcus mutans, encoding a transcriptional
repressor, that interacts with gbpC mRNA and prevents its
cleavage by RNase J2 [37]. Another possibility is that the
speB mRNA 5′ UTR is targeted by a sRNA regulating speB
expression, which in turn would trigger the processing of
the targeted transcript. This is the case in C. perfringens,
where VR-RNA binds to the 5′ UTR of colA mRNA, result-
ing in the processing of this transcript by RNase Y and an
increase in its stability [9,38].
Notably, both RNase Y processing sites of speB mRNA 5′
UTR were mapped after a G. A preference for a G upstream of
RNase Y processing sites was previously described in S. aureus
[13]. Here, we used speB mRNA as a model target to deter-
mine the importance of this residue for RNase Y activity. We
show for the first time that a G is required for in vivo
processing of speB mRNA by RNase Y. A similar sequence
preference has been recently described for RNase E, the func-
tional equivalent of RNase Y in Gram-negative bacteria.
Global mapping of RNase E processing events in Salmonella
enterica revealed the preference for a uridine (U), 2 nt down-
stream of the cleavage site [34]. Mutation of this nucleotide
strongly reduced the processing of the mRNA targets by
RNase E, both in vitro and in vivo [34]. Since structural data
showed that RNase E interacts with an RNA substrate, 2 nt
downstream of the cleavage site, the authors proposed a
model in which the U at this position induces a conforma-
tional change in the catalytic site, which favors the processing.
A similar explanation might be applicable to RNase Y, how-
ever the crystal structure of this enzyme is not available and
therefore the mechanism used to recognize the G is challen-
ging to investigate.
We observed that the amount of transcripts starting at the
first RNase Y cleavage site (–137 nt) was higher than the
transcripts starting at the second cleavage site (–131 nt)
(Fig. 2A,B). A possible explanation is that the latter are
degraded faster than the former. An alternative hypothesis is
that RNase Y cleaves at these two positions with a different
efficiency. In this scenario, other stimuli sensed by RNase Y
could influence the preferred location for the processing.
Different determinants affecting RNase Y activity, such as
secondary structures of the RNA target and RNase Y inter-
acting proteins, have independently been investigated in other
Gram-positive bacteria. Although previous studies showed
that RNase Y is sensitive to secondary structures located
downstream of the processing events [10,12], a recent tran-
scriptomic analysis in B. subtilis did not identify any
consensus motif (neither sequence nor RNA structure) in
proximity of RNase Y cleavages [39]. Our mutational study
indicates that the sequence requirement (i.e. G upstream the
cleavage site) is essential for correct processing. However, we
cannot exclude that secondary structures play a role in con-
cert with the G residue in determining the RNase Y cleavage
site location in S. pyogenes. In the structural prediction of speB
mRNA 5′ UTR, we did not detect a double-stranded structure,
6 nt downstream of the cleavage sites that would resemble the
structure described for S. aureus and B. subtilis. Therefore, if
the structure is also involved in determining RNase Y target
specificity, the mechanism is probably different from the one
proposed in the aforementioned bacteria.
It has recently been shown that the processing by RNase Y
of specific mRNA targets in B. subtilis depends on the so-
called Y-complex, composed of RNase Y and interacting pro-
teins [39,40]. Overall, the exact requirements for RNase Y
activity in vivo still need to be determined, and current knowl-
edge indicates that this enzyme may exhibit various charac-
teristics in different bacteria. Our characterization of RNase Y
processing of speB mRNA 5′ UTR provides new insights into
RNase Y determinants required for processing in S. pyogenes
that could facilitate the study of other RNase Y targets.
Indeed, introducing point mutations in the G residue of
other RNase Y substrates might serve as a useful tool to
investigate those transcripts without deleting RNase Y and
without disrupting any putative complex formed by RNase
Y and potential interacting proteins.
We observed that RNase Y had an effect on the stability of
the primary transcript (T2), as it was cleaved by this RNase. In
a previous study, only two speB transcripts (long and short)
were identified by Northern blot analyses. The longer tran-
script, which was stabilized in Δrny compared to WT [11],
could correspond to the isoforms here named T2. The authors
proposed that by cleaving speB mRNA, RNase Y yields a
shorter speB transcript, more stable than its precursor [11].
However, the origin of this processed isoform remains
unclear, and we hypothesize that it might derive from the
processing by unidentified RNase(s) observed in our study.
We demonstrated that the decrease of speB mRNA abun-
dance in Δrny was not due to a reduction of speB mRNA
stability (Fig. 4C). Instead, our data underpin a model in
which RNase Y controls speB expression indirectly via an
unidentified transcriptional regulator. A possible candidate
that was proposed to be involved in RNase Y control of
speB expression is RopB, an activator of speB transcription
[7]. Indeed, ectopic expression of ropB in Δrny, restored the
production of SpeB to the WT level. However, it is likely that
the downregulation of speB mRNA in Δrny is not due to
RopB activity since the stability of the ropB transcript is highly
increased in Δrny [27,29], and this would result instead in
increased speB expression. We cannot conclude that ropB
mRNA levels are the same in our settings, since different
strains and growth conditions were used in our study. It is
also possible that more than one transcriptional factor con-
tributes to the RNase Y-mediated regulation of speB. Of note,
SIP, which activates speB expression through RopB, was co-
transcribed with speB and its expression was downregulated in
Δrny. Consequently, it is possible that a negative feedback
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loop involving SIP is established, explaining the strong reduc-
tion of speB mRNA level in Δrny.
Overall, the mechanisms by which RNases regulate virulence
gene expression in S. pyogenes are yet to be fully understood.
For instance, a group of transcripts encoding virulence proteins
(e.g. Streptolysin S and Streptodornase D) are highly stable
during stationary growth phase as their degradation – by
RNases J1/J2 and PNPase – is delayed compared to other
mRNAs [41,42]. It was proposed that the differences in RNA
decay initiation of these two groups of mRNAs rely on features
(e.g. secondary structures) in the mRNA 5′ UTRs [42].
However, other unidentified requirements, apart from the 5′
UTR, are also needed to discriminate the different sets of
mRNAs to allow differential stability of virulence-related
mRNAs [31]. RNase Y is involved in the regulation of virulence
in S. pyogenes, but to date no regulatory mechanisms have been
elucidated. Here, we established that the predominant mechan-
ism of RNase Y-based regulation of speB expression is at the
level of transcription. However, we cannot exclude the possibi-
lity that RNase Y processing events of speB transcript exert a
more significant regulation under different conditions – for
example, in response to specific environmental stimuli.
In the present study, we have addressed the complexity of
RNase Y regulation of a major virulence factor in S. pyogenes.
Our data raise further important questions regarding the exact
role, either direct or indirect, of RNase Y in the modulation of
virulence in this bacterium, and may pave the way for further
studies on the relevance of RNA processing as a regulatory
mechanism of pathogenicity factor expression.
Materials and methods
Bacterial culture conditions
Bacterial strains are listed in Supplementary Table I. S. pyo-
genes SF370 (M1 GAS) was grown in THY medium (Todd
Hewitt Broth) supplemented with 0.2% yeast extract
(Servabacter®) without shaking at 37°C, with 5% CO2. For
growth on solid medium, TSA blood agar (TrypticaseTM Soy
Agar, Becton Dickinson) supplemented with 3% defibrinated
sheep blood (Oxoid) was used. Escherichia coli was grown as
described in [43]. When required, antibiotics were added to
the medium at the following final concentrations: 3 μg/ml
erythromycin and 300 μg/ml kanamycin for S. pyogenes;
300 μg/ml erythromycin and 50 μg/ml kanamycin for E. coli.
Construction of gene deletion mutants
Chromosomal deletions of rnhB, mrnC yhaM (SPy_0267),
pnpA, rnr and speB in S. pyogenes were performed using the
Cre-Lox recombination system [44] as described in [43] with
the following modifications. Briefly, regions upstream and
downstream of rnhB, mrnC, yhaM, pnpA, rnr and speB were
amplified by PCR from WT genomic DNA using oligos listed
in Supplementary Table I. The last 156 nt of the speB ORF
were not removed in order to keep the ribosome binding site
(RBS) of the downstream gene (SPy_2038). These upstream
and downstream regions were ligated to the lox71-ermAM/B-
lox66 and cloned in suicide vectors for S. pyogenes
(pSEVA141 for yhaM and speB; pUC19 for rnhB, mrnC and
pnpA; pJET1.2 for rnr) (plasmids in Supplementary Table I).
Prior to transformation in S. pyogenes, the plasmids were
linearized in the ampR gene with SacII (for pSEVA141) or
with PvuI (for pUC19 and PJET1.2). Insertion of the lox71-
ermAM/B-lox66 cassette was checked by PCR and DNA
sequencing (Microsynth, Switzerland). The ermAM/B cassette
was then removed from ΔrnhB, ΔmrnC, ΔpnpA, Δrnr and
ΔspeB deletion mutants by expressing the Cre recombinase.
The integrity of the generated strains was checked by PCR
and DNA sequencing (Microsynth, Switzerland).
Construction of chromosomal complemented Δrny strain
The S. pyogenes Δrny strain was complemented on the chro-
mosome. A fragment including the rny gene together with the
upstream region and the TT3 transcriptional terminator [45]
was generated by PCR with OLEC3584/OLEC3579. The
downstream region of rny and the lox71-ermAM/B-lox66
cassette were amplified by PCR with OLEC3480/OLEC3572
and OLEC2000/OLEC3585, respectively. The PCR products
obtained were ligated and cloned in a suicide vector for S.
pyogenes (pRS426 ATCC® 77107™) by applying the homolo-
gous recombination system of Saccharomyces cerevisiae S228C
[46]. S. cerevisiae cells were grown in YPD medium (Yeast
extract Peptone Dextrose) at 30°C until OD620 nm of 0.6 and
washed with water. Following an additional wash with SORB
buffer (100 mM lithium acetate; 10 mM Tris-HCl pH 8; 1 mM
EDTA pH 8; 1M sorbitol), the cells were resuspended in
SORB buffer containing boiled salmon sperm (1.43 mg/ml).
The competent cells obtained (50 µl) were incubated in PEG-
buffer (100 mM lithium acetate; 10 mM Tris-HCl pH 8; 1 mM
EDTA pH 8; 40% PEG3350) for 30 min with the PCR frag-
ments (100 ng each) and plasmid pRS426 was linearized with
BamHI/KpnI. S. cerevisiae was transformed by heat shock of
15 min at 42°C. Positive clones (growing on plates without
uracil) were selected, pooled and the plasmids were extracted
with the QIAprep® Spin Miniprep Kit following the manufac-
turer’s instructions. The lysis step was modified as follows: the
cells were mixed with zirconium/glass beads (Ø 0.1 mm,
Roth) and vortexed for 15 min. The heterogeneous plasmid
preparation was introduced by transformation in E. coli
TOP10 to obtain isolated plasmids carrying the correct insert.
The plasmid was linearized with PvuI (cleaving in the ampR
cassette) and introduced by transformation in electrocompe-
tent S. pyogenes.
Bacterial transformation
E. coli cells were transformed using a standard heat-shock
protocol described in [47]. S. pyogenes competent cells for
the deletion of rnhB, mrnC, yhaM (SPy_0267), pnpA, rnr
and speB were prepared as in [43]. For transformation of S.
pyogenes (WT or deletion mutants) with plasmids, competent
cells were generated according to the procedure shown in [48]
with some modifications. The electroporation was performed
with a pulse of 1.8 kV, 400 Ω, 25 μF.
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Construction of plasmids for speB ectopic expression
The speB 5′ UTR and coding sequence were amplified from
WT genomic DNA using primers OLEC7970/7971 and ligated
to a gyrA promoter from Streptococcus agalactiae (PgyrA
amplified from pEC455 using OLEC7968/7969) by PCR-
mediated ligation with OLEC7968/OLEC7971. The resulting
fragment was cloned in pEC85 digested with XbaI-EcoRI to
generate plasmid pEC2146, which was used as a template to
construct the variant plasmids with mutated speB 5′ UTR. The
mutations were introduced with the two-stage PCR metho-
dology [49], with primers listed in Supplementary Table I.
RNA extraction
Total RNAs from S. pyogenes were prepared from cultures
harvested at early-logarithmic (EL; OD620nm = 0.1), mid-loga-
rithmic (ML; OD620nm = 0.25) and early-stationary (ES;
OD620nm = 0.4) growth phases. The samples were mixed with
1:1 ice-cold acetone/ethanol and the RNAs were precipitated
using isopropanol (Sigma) following extraction with TRIzol
(Life Technologies)/chloroform (Sigma). RNA concentrations
were measured using NanoDrop (Thermo Scientific) and
RNA integrity was determined by agarose gel electrophoresis.
Rifampicin assay
Rifampicin (Sigma-Aldrich) was dissolved in methanol and
added to the cultures at ES growth phase at a final concentra-
tion of 250 μg/ml. 25 ml of cultures were harvested immedi-
ately (0 min) and at defined time points (5, 10, 20, 30, 45 min)
after the addition of rifampicin.
Northern blot analysis
Total RNA (15 μg) was separated on a 1% agarose gel (1X
MOPS (20 mM MOPS free acid, 5 mM sodium acetate, 1 mM
EDTA, pH 7.0), 6.6% formaldehyde), in 1X MOPS buffer
containing 0.7% formaldehyde. The RNAs were transferred
onto a Nylon Hybond N+ membrane (GE Healthcare). The
transfer was carried out on a capillary system overnight at
room temperature in 20X SSC buffer. The cross-linking of
RNAs on the 6X SSC-rinsed membrane was performed with
UV (2X autocrosslinking, UV Stratalinker 1800). The oligo-
nucleotides primers (Supplementary Table I) were labelled
with gamma-32P ATP (Hartmann analytics) using the T4
Polynucleotide Kinase (T4-PNK, Fermentas) and purified
over G-25 columns (GE Healthcare) as previously described
[33]. The denatured primers were incubated with the mem-
branes in hybridization buffer (Rapid-hyb buffer, GE
Healthcare) overnight at 50°C. The membranes were washed
with 1X SSC + 0.1% SDS for 20 min at 50°C and subsequently
with 0.5X SSC + 0.1% SDS. The radioactive signal was visua-
lized after 2 or 3 days of exposure using a phosphorimager
(Typhoon Fla 9000, Fujifilm). 16S rRNA was used as a loading
control. The approximate sizes of RNA transcripts were esti-
mated using the RiboRuler High Range Ladder (Thermo
Scientific). Each experiment was performed at least in inde-
pendent triplicates.
Calculation of RNA half-life
The transcript abundance quantification was performed by
densitometry using Fiji [50]. The half-lives were calculated
by fitting an exponential decay curve to time points measured
from three independent blots. The comparison of the half-
lives between WT and Δrny or between Δrny::rny and Δrny
was done using a t-test.
Primer extension
Primer extension was performed as described in [43]. The sizes
of cDNA fragments were estimated using the 30–330-bp AFLP®
DNA ladder (Invitrogen). Alternatively, a sequencing ladder
was generated with a dideoxy chain termination reaction, using
the SequenaseTM Version 2.0 DNA Sequencing Kit (Affymetrix
USB), following the manufacturer’s instructions. The DNA
template used during the termination reaction was generated
by PCR fromWT genomic DNA using OLEC3903/OLEC3972.
Luminescence assay for speB promoter activity
The plasmid-based reporter system (pLZ12Km2-P23R:TA:
ffluc, Addgene plasmid gift from Thomas Proft) described in
[51] was used to construct plasmid pEC2248, in which the
expression of ffluc (firefly luciferase gene) is under the control
of the speB promoter region (from –940 nt to –697 nt relative
to the speB start codon). This region contains both P and P1
promoters (PspeB) and the putative binding sites of speB tran-
scriptional regulator RopB [23,26]. Briefly, pLZ12Km2-P23R:
TA:ffluc was digested with SacI and SacII (Thermo Scientific)
to remove the lactococcal constitutive promoter P23 [51,52].
PspeB was amplified from WT genomic DNA using primers
OLEC8386/OLEC8387 and cloned in pLZ12Km2-P23R:TA:
ffluc. WT, Δrny, and Δrny::rny cells containing the constructs
for studying the activity of speB promoters were grown until
ML and ES growth phases. Beetle luciferin potassium salt
(Promega) was added to 200 μl of cultures at a final concen-
tration of 50 ng/μl in a white opaque 96-well microtiter plate
(Greiner Bio-OneTM). Luminescence was measured using a
microplate reader (BioTekTM Cytation 3) with an integration
time of 1 sec, a gain of 120, and a read height of 1 mm. The
signal was normalized with the OD620 nm and with the luci-
ferase signal obtained from the constitutive promoter P23.
The experiments were carried out in independent biological
triplicates, each with technical triplicates.
Exoprotein precipitation
S. pyogenes cultures were grown until ML and ES growth
phases, centrifuged and subsequently filtered using 0.45 μm
syringe filter (VWR) to obtain cell-free supernatants. The
proteins were precipitated with 10% of ice-cold trichloracetic
acid and resuspended in 70 μl of 1 M Tris-HCl, pH 8.0. Equal
volumes of exoprotein preparation were separated by SDS-
PAGE (sodium dodecyl sulfate – polyacrylamide gel electro-
phoresis) using 15% polyacrylamide gel. The gels were stained
with Coomassie Brilliant Blue (Sigma-Aldrich) and imaged
using CanoScan LiDE 700F. The approximate masses in
1344 L. BROGLIA ET AL.
kilodaltons (kDa) of the proteins were estimated using
PageRulerTM Plus Prestained Protein ladder (Thermo Fisher).
RNA secondary structure prediction
The RNA structure of speB 5′ UTR (Fig. S3A) was estimated
by calculating the minimum free energy (RNAfold, MFE in
Kcal/mol) [53] of 25 nt sequences at each position from
100 nt upstream to 100 nt downstream of the RNase Y
cleavage site (at –137 nt from speB ATG). The structure
prediction (Fig. S3B) was visualized by using VARNA [54].
RNA sequencing
Total RNA was extracted from S. pyogenes WT grown until ES
phase for RNA sequencing or until ML phase for sRNA sequen-
cing, andDNAwas removed using TurboDNase (Ambion). After
sample quality control using the bioanalyzer (RNA 6000 Nano
Kit) and Qubit (RNA BR Assay, Invitrogen), the rRNAs were
removed with Ribo-Zero rRNA Removal Kit Bacteria (Illumina).
To include both primary and processed transcripts in the libraries,
the 5′ triphosphate RNAs were converted in 5′ monophosphate
RNAs using TAP (Tobacco Acid Pyrophosphatase, Epicentre).
After treatment with T4 Polynucleotide kinase (Thermo
Scientific), small and large RNAs were purified into two separated
fractions (short and long RNAs) using RNA Clean &
Concentrator kit (Zymo Research). RNAs fragments of 200 nt
were further produced from the long RNA fraction by chemical
fragmentation with NEBNext Magnesium RNA Fragmentation
Module (NEB E61505). RNA purification steps were done
using Phenol:Chloroform:Isoamylalcohol (Roth) followed by
Chloroform:Isoamylalcohol (Sigma) or RNA Clean &
Concentrator kit (Zymo Research). The cDNA libraries were
prepared using NEXTflex® Small RNA Sequencing Kit v3 (Bioo
Scientific) for both short and fragmented RNA fractions, follow-
ing the manufacturer’s instructions with some modifications.
After step G, consisting of 22 cycles of PCR, the final purification
of the cDNA library was done with Agencourt AMPure XP beads
(Beckman Coulter), following step I of the NEXTflex Rapid
Directional qRNA-Seq Kit protocol (Bioo Scientific). cDNA
library quality control was checked using Qubit (dsDNA HS
Assay, Invitrogen) and bioanalyzer (High sensitivity DNA kit,
Agilent). The sequencing was performed using the HiSeq3000
instrument at the Max Planck-Genome-Centre Cologne (MP-
GC), with a paired end strategy and 150 nt of read length.
Read processing
FastQC (v0.11.5) was used to assess the quality of the data.
Reads with quality score <10 were filtered and eliminated if
smaller than 22 nt and adapter sequences were removed using
Cutadapt (v1.11) [55]. The mapping of the reads against the S.
pyogenes reference genome (NC_002737.2) was performed with
STAR (v2.5.2b) in both ‘random best’ and ‘end to end’ modes
[56]. The resulting BAM files were sorted and indexed using
Samtools (v1.3.1). To detect and filter possible PCR artefacts,
four random bases UMIs (Unique Molecular Identifiers) were
included at the RNA 3′ and 5′ ends, during the library prepara-
tion and treated with the UMI Tools (v0.4.1). The coverage files
(total, 5ʹ and 3ʹ ends) were produced using a custom script with
the HTSeq library (v0.9.1) and visualized using the Integrative
Genomics Viewer (IGV) [57].
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